Sign In to Follow Application
View All Documents & Correspondence

Single Crystal Platy Barium Sulfate In Cosmetic Compositions

Abstract: A cosmetic composition comprising: (i)   from about 0.01 to about 10% of single-crystal platy barium sulfate by weight 5 of the composition; (ii)  from about 0.1 to about 10% of a water-insoluble powdered acrylic polymer in porous particle form; and (iii)  a cosmetically acceptable carrier, wherein the number average particle size of the single-crystal platy barium sulfate is from 8 to 15 microns.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
18 June 2009
Publication Number
47/2010
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2014-06-16
Renewal Date

Applicants

HINDUSTAN UNILEVER LIMITED
HINDUSTAN LEVER HOUSE, 165-166 BACKBAY RECLAMATION, MUMBAI 400 020, INDIA

Inventors

1. SIMOULIDIS SOFIA
33 WILTON AVENUE APT.3, NORWALK, CONNECTICUT 06851, UNITED STATES OF AMERICA.
2. SICILIANO MARCINA
UNILEVER HOME & PERSONAL CARE USA 40 MERRITT BOULEVARD, TRUMBULL, CONNECTICUT 06611, UNITED STATES OF AMERICA.
3. POLONKA JACK
UNILEVER HOME & PERSONAL CARE USA 40 MERRITT BOULEVARD, TRUMBULL, CONNECTICUT 06611, UNITED STATES OF AMERICA.

Specification

FORM - 2
THE PATENTS ACT, 1970
(39 of 1970) &
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)


SINGLE -CRYSTAL PLATY BARIUM SULFATE IN COSMETIC COMPOSITIONS
HINDUSTAN UNILEVER LIMITED, a company incorporated under
the Indian Companies Act, 1913 and having its registered office
at 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India

The following specification particularly describes the invention and the manner in which it is to be performed





SINGLE-CRYSTAL PLATY BARIUM SULFATE IN COSMETIC COMPOSITIONS
BACKGROUND OF THE INVENTION
5
Field of the Invention
The invention relates to compositions for improving the appearance of skin, particularly to provide good coverage over imperfections such as pores and uneven skin tone, while retaining a natural skin appearance.
10
The Related Art
A matte effect is often sought from facially applied cosmetics. The matte finish overcomes the shiny effect engendered by greasy skin, particularly under hot and humid conditions. Absorbent fillers such as talc, silica, kaolin and other inorganic particulates
15 have been used to achieve the effect by their optical properties.
Imperfect skin can be hidden in two ways through manipulation of light transmission. In the first, components of the cosmetic may simply reflect light back toward the source. An alternative approach is referred to as achieving a soft focus effect. Here the incoming 20 light is distorted by scattering (lensing). Component^ of the color cosmetic in this mechanism operate as lenses to bend and twist light into a variety of directions.
While it is desirable to hide imperfect skin through a matte effect, there is also a desire to achieve a healthy skin radiance. A cosmetic covering that is too opaque hides the skin 25 under a paint-like coating. Imperfections are hidden but there is no radiance. Some refer to this as whitening. Where light transmission is insufficiently hindered, the opposite occurs. Here the glow may be healthy but aesthetically displeasing skin topography and color may now be apparent.
30 US 5 997 890 (Sine et al.), US 5 972 359 (Sine et al.), and US 6 174 533 B1 (SaNogueira, Jr.) are all directed to topical compositions to provide good coverage of skin imperfections. The solution proposed by these documents is the use of a metal oxide with a refractive index of at least about 2 and a neat primary particle size of from about 100 to about 300 nm. Preferred particulates are titanium dioxide, zirconium oxide and
35 zinc oxide.

-2-
A significant disadvantage of titanium dioxide and zinc oxide is the whitening effect upon the skin. An undesirable ashen appearance is unfortunately created.
US 2005/0287092 A1 (Liechty et a\.) reports make-up and skincare compositions in 5 powder form which allow the natural grain of the skin to show through. These powders are based upon barium sulfate particles coated with an N-acylamino acid such as lauroyllysine. Also present is at least one elastomeric organopolysiloxane powder or a polymethylmethacrylate powder.
10 US 2005/0079190 A1 (Polonka) discloses the use of solid single-crystal flat platy particles which in cosmetic skin care compositions provide consumer-desired properties of the appearance of natural skin radiance. Suitable platy particles include bismuth oxy-chloride, aluminum oxide, zirconium oxide and boron nitride.
15 US 6 495 123 (Faryniarz et al.) and US 6 432 389 B1 (Hansenne et al.) describe cosmetic compositions with improved skinfeel properties delivered through polymeric porous particles such as methyl methacrylate crosspolymers.
A challenge which has not been fully met by the known art is delivery of a composition 20 with appropriate optics to achieve both soft focus and radiance properties in a system that still provides excellent skinfeel. Still further there is a need which has not previously been fully met for a soft focus system that reduces "red wavelength" to hide fine lines and wrinkles.
25
SUMMARY OF THE INVENTION
A cosmetic composition is provided which includes:
(i) from 0.01 to 10% of single-crystal platy barium sulfate by weight of the composition; 30 (ii) from 0.1 to 10% of a water-insoluble powdered acrylic polymer in porous particle form; and (iii) a cosmetically acceptable carrier



DETAILED DESCRIPTION OF THE INVENTION
Now it has been found that a combination of single-crystal platy barium sulfate and a water-insoluble powdered acrylic polymer in porous particle form provide a cosmetic 5 composition which applied to the face achieves soft focus with radiance effect. The treated facial area achieves a natural end-finish. Skinfeel is excellent without drawbacks associated with inorganic particulate formulated cosmetics.
The inventive compositions empfoy solid particles that are singfe-crysfaf, flat and platy, to 10 impart a radiant appearance to the skin upon application. By virtue of being flat single crystals, the particles deliver high reflectance. Flat platy crystals can generate this natural radiant appearance via optical reflectance. The number average (diameter) particle size may range from 0.1 to 30 micron, but preferably from 6 to 18 micron, and optimally from 8 to 15 micron. 15
Size of the platy particles is important because smaller particles reflect too little light to be readily apparent, while larger particles would be visible as discrete objects and thereby provide too much glitter or reflectance. The reflectance (index of refraction) of the platy crystal cannot be too high. Too high an index of refraction will inhibit the transmission of 20 natural skin color and create a cosmetic sheen. With too low an index of refraction, the particles will have approximately the same index of refraction as the skin or the product film, resulting in a weak reflectance, thereby diminishing the appearance of radiance.
Single-crystal structure is also key because the smoothness of the crystal surface 25 minimizes opacity or diffuse scattering effects, which would lead to an artificial cosmetic effect. Single-crystal structure maximizes the smooth crystalline surface area. As the facet of a crystal is the smoothest surface possible, it maximizes the degree of reflectance wbJJe minimizing the opacity. The product is designed to Impart radiance while maintaining natural skin tone, which is achieved by controlling the opacity of the 30 composition.
The single-crystal, flat platy particles of this invention are barium sulfate. These particles preferably are not coated, especially not coated with organic coatings such as N-acyl amino acids (e.g. lauroyilysine). Amounts of the barium sulfate may range from 0.01 to 35 10%, preferably from 0.1 to 5%, more preferably from 0.1 to 1%, optimally from 0.2 to 0.5% by weight of the composition.

-4-
A second element of compositions according to the present invention is that of a water-insoluble powdered acrylic polymer in porous particle form. By the term "porous" is meant an open or closed cell structure. Preferably the particles are spherical but not boHow beads. Average particle size may range from 0.1 to WO, preferably from 1 to 50, 5 more preferably greater than 5 and especially from 5 to 16, optimally from 6 to 10 micron. Acrylic polymers of this invention can be formed from acrylic monomers including acrylic acid, methacrylic acid, methylacrylate, ethylacrylate, acrylamide and mixtures thereof. Additionally the acrylic polymers may be copolymers formed from copolymerization of acrylic monomers with non-acrylic monomers selected from ethylene, propylene, maleic
10 acid, acrylonitrile, vinyl pyrrolidone, butadiene, styrene, octene, vinyl chloride, vinylidene chloride and mixtures thereof. The polymers are especially useful in cross-linked form. Cells of the porous polymer may be filled by a gas which can be air, nitrogen or a hydrocarbon. Oil Absorbance (castor oil) is a measure of porosity and may range from 90 to 500, preferably from 100 to 200, optimally from 120 to 180 ml/100 grams. Density of
15 the particles may range from 0.08 to 0.55, preferably from 0.15 to 0.48 g/cm3.
Particularly preferred for this invention is a synthetic copolymer of methyl methacrylate cross-linked with glycol dimethacrylate. It has the empirical formula (C10H14O4.C5HaO2) and has been assigned Chemical Abstracts Service (CAS) No. 25777-71-3. It is also 20 described at page 808, volume 1, International Cosmetic Ingredient Dictionary and Handbook (Seventh Edition, 1997), published by The Cosmetic, Toiletry, and Fragrance Association (Washington, D.C.). It is known by its INCI name of Methyl Methacrylate Crosspolymer.
25 Methyl Methacrylate Crosspolymer is commercially available from Presperse Incorporated (Piscataway, NJ), under the trademark Ganzpearl® GMP-0820. The product specifications of Ganzpearl® GMP-0820 include: spherical, white fine powder having a particle size of 4-10.5 \im, preferably 4-8 urn, high oil absorption, creamy feel, good slip, specific gravity of 1.10 to 1.25, film-forming, viscosity increasing. Its loss on
30 ignition (400°C) is less than 0.1%, and on drying (105° C/2 hours) is less than 2.0%. The surface residual monomer content of Ganzpearl® GMP-0820 is less than 20 ppm, with total residual monomer content being less than 100 ppm. The cross-linking density of this very high molecular weight polymer is circa 43 wt % [crosslinking monomer/(crosslinking monomer+base monomer)].
1 8 JUN 2009


-5-
Methyl methacrylate crosspolymers are also commercially available from Nihon Junyaku under the trademark Jurymer MP-1P and from Tomer under the trademark Microsphere M-305.
5 Characteristically the particulates of methyl methacrylate cross-polymers according to this invention have a particle size of less than 20 ^m, preferably less than 10 |xm.
Amounts of the water-insoluble acrylic polymer in porous particle form may range from 0.01 to 10%, preferably from 0.1 to 5%, optimally from 0.3 to 2% by weight of the 10 composition.
Optionally other pigments may be useful in formulas of the present invention. Of special note are titanium dioxide, zinc oxide or zirconium oxide. Titanium dioxides may range in number average particle size from 100 to 800 nm, preferably from 400 to 500 nm. Zinc
15 and zirconium oxides should be micronized having number average particle size less than 300 nm, preferably less than 200 nm, more preferably less than 100 nm and optimally Jess than 85 nm. Generally the particle sizes can range from 0.01 to 280 nm, more preferably from 1 to 200 nm, even more preferably from 10 to 95 nm, and optimally from 25 to 75 nm.
20
The amount of titanium oxide, zinc oxide or zirconium oxide may range from 0.1 to 20%, preferably from 0.5 to 10%, optimally from 1 to 5% by weight of the cosmetic composition.
A still further pigment type for the purposes of this invention are the titanium dioxide
25 coated micas. These include Timiron® MP-10 (particle size range 10,000-30,000 nm),
Timiron® MP-14 (particle size range 5,000-30,000 nm), Timiron® MP-30 (particle size
range 2,000-20,000 nm), Timiron® MP-101 (particle size range 5,000^5,000 nm),
Timiron® MP-111 (particle size range 5,000-40,000 nm), Timiron® MP-1001 (particle size
range 5,000-20,000 nm), Timiron® MP-155 (particle size range 10,000-40,000 nm),
30 Timiron® MP-175 (particle size range 10,000^0,000), Timiron® MP-115 (particle size
range 10,000-40,000 nm), and Timiron® MP-127 (particle size range 10,000-40,000 nm).
Most preferred is Timiron® MP-111 and the irridescent blue type known as Timiron® Silk
Blue, both available from Rona/EM Industries Incorporated, and mixtures thereof. The
weight ratio of titanium dioxide coating to the mica platelet may range from 1:10 to 5:1,
35 preferably from 1:1 to 1:6, more preferably from 1:3 to 1:4 by weight. The mica platelets


-6-
may range from 0.1 to 5%, preferably from 0.5 to 3%, more preferably from 0.8 to 2%, optimally from 1 to 1.5% by weight of the composition.
A variety of materials may be present in the compositions to serve as cosmetically 5 acceptable carriers. Foremost is water as a carrier. Amounts of water may range from 1 to 90%, preferably from 30 to 80%, optimally from 50 to 70% by weight of the composition.
Emollient materials may be inducted as carriers in compositions of this invention. These 10 may be in the form of silicone oils, synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from 0.1 to 95%, preferably between 1 and 50% by weight of the composition.
Silicone oils may be divided into the volatile and non-volatile variety. The term "volatile" 15 as used herein refers to those materials which have a measurable vapor pressure at ambient temperature (20-25°C). Volatile silicone oils are preferably chosen from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms. In many liquid versions of compositions according to the present invention, the volatile silicone oils may form a relatively large component of the 20 compositions as carriers. Amounts may range from 5% to 80%, preferably from 20% to 70% by weight of the composition.
Non-volatile silicone oils useful as an emollient material include polyalkyi siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially non-volatile 25 polyalkyi siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 x 10"6 to 0.1 m2/s at 25°C. Among the preferred non-volatile emollients useful in the present compositions are the polydimethyl siloxanes having viscosities from about 1 x 10'5 to about 4 x W4 m2/s at 25°C.
30 Organopolysiloxane cross-polymers can be usefully employed. Representative of these materials are dimethicone/vinyl dimethicone cross-polymers and dimethicone cross-polymers available from a variety of suppliers including Dow Corning (9040, 9041, 9045, 9506 and 9509), General Electric (SFE 839), Shin Etsu (KSG-15, 16 and 18 [dimethicone/phenyl vinyl dimethicone cross-polymer]), and Grant Industries (Gransil
35 brand of materials), and lauryl dimethicone/vinyl dimethicone cross-polymers supplied by Shin Etsu (e.g. KSG-31, KSG-32, KSG-41, KSG-42, KSG-43 and KSG-44). Amounts of


-7-
the aforementioned silicone elastomers will usually be present from 0.1 to 20% by weight dissolved usually in a volatile silicone oil such as cyclomethicone.
When silicones are present in large amounts as carrier and water is also present, the systems may be oil continuous. These normally will require emulsification with a water-in-oil emulsifier such as a dimethicone copolyol (e.g. Abil EM-90 which is cetyl dimethicone copolyol).
Among (he ester emo//fents are:
10
a) Alkenyl or alky! esters of fatty acids having 10 to 20 carbon atoms. Examples thereof include isoarachidyl neopentanoate, isodecyl neopentanoate, isononyl isonanoate, cetyl ricinoleate, oleyl myristate, oleyl stearate, and oleyl oleate.
b) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
15 c) Polyhydric alcohol esters such as ethylene glycol mono- and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters,
20 polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene
glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory. Particularly useful are pentaerythritol, trimethylolpropane and neopentyl glycol esters of C1-C30 alcohols. Exernpletive is pentaerythrityl
25 tetraethylhexanoate.
d) Wax esters such as beeswax, spermaceti wax and tribehenin wax.
e) Sterols esters, of which cholesterol fatty acid esters are examples thereof.
f) Sugar ester of fatty acids such as sucrose polybehenate and sucrose polycottonseedate.
30
Of particular use also are the C12-15 alkyl benzoate esters sold under the Finsolve brand.
Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, C11-C13 isoparaffins, polyalphaolefins, and especially isohexadecane, 35 available commercially as Permethyl 101A from Presperse Inc.
1 8 JUN 2009

-8-
Humectants of the poiyhydric alcohol-type can be employed as cosmetically acceptable carriers. Typical poiyhydric alcohols include polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl 5 sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, glycerol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. The amount of humectant may range anywhere from 0.5 to 50%, preferably between 1 and 15% by weight of the composition. Most preferred is glycerol (also known as glycerin). Amounts of glycerin may range from 1% to 50%, preferably from 10 to 35%, optimally from 15 to 10 30% by weight of the composition.
Besides cosmetically acceptable carriers, the compositions of this invention may include a variety of other functional ingredients. Sunscreen actives may be included in compositions of the present invention. These will be organic compounds having at least one
15 chromophoric group absorbing within the ultraviolet ranging from 290 to 400 nm. Chromophoric organic sunscreen agents may be divided into the following categories (with specific examples) including: p-aminobenzoic acid, its salts and its derivatives (ethyl, isobutyl, glyceryl esters and p-dimethylaminobenzoic acid); anthranilates (o-aminobenzoates; methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl, terpinyl, and
20 cyclohexenyl esters); salicylates (octyl, amyl, phenyl, benzyl, menthyl, glyceryl, and dipropyleneglycol esters); cinnamic acid derivatives (menthyl and benzyl esters, alpha-phenyl cinnamonitrile and butyl cinnamoyl pyruvate); dihydroxycinnamic acid derivatives (umbelliferone, methylumbelliferone and methylaceto-umbelliferone); trihydroxycinnamic acid derivatives (esculetin, methylesculetin, daphnetin, and the glucosides, esculin and
25 daphnin); hydrocarbons (diphenylbutadiene and stilbene); dibenzalacetone and benzalacetophenone; naphtholsulfonates (sodium salts of 2-naphthol-3,6-disulfonic and of 2-naphthol-6,8-disulfonic acids); dihydroxy-naphthoic acid and its salts; o- and p-hydroxybiphenyldisulfonates; coumarin derivatives (7-hydroxy, 7-methyl and 3-phenyl); diazoles (2-acetyl-3-bromoindazole, phenyl benzoxazole, methyl naphthoxazole and
30 various aryl benzothiazoles); quinine salts (bisulfate, sulfate, chloride, oleate and tannate); quinoline derivatives (8-hydroxyquinoline salts and 2-phenylquinoline); hydroxy- or methoxy-substituted benzophenones; uric and vilouric acids; tannic acid and its derivatives (e.g. hexaethylether); (butyl carbityl) (6-propyl piperonyl) ether; hydroquinone; benzophenones (oxybenzone, sulisobenzone, dioxybenzone, benzoresorcinol, 2,2',4,4'-
35 tetrahydroxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone and
octabenzone); 4-isopropyldibenzoylmethane; butylmethoxydibenzoylmethane; etocrylene;
18 JUN 2009


-9-
and 4-isopropyl-dibenzoylmethane. Particularly useful are 2-ethylhexyl p-
methoxycinnamate, 4,4'4-butyl methoxydibenzoylmethane, 2-hydroxy-4-
methoxybenzophenone, octyldimethyl p-aminobenzoic acid, digalloyltrioleate, 2,2-dihydroxy-4-methoxybenzophenone, ethyl 4-[bis(hydroxypropyl)]aminobenzoate, 2-5 ethylhexyl-2-cyano-3,3-diphenylacrylate, 2-ethylhexylsalicylate, glyceryl p-aminobenzoate, 3,3,5-trimethylcyclohexylsalicylate, methylanthranilate, p-dimethylaminobenzoic acid or aminobenzoate, 2-ethylhexyl p-dimethylaminobenzoate, 2-phenyibenzimidazole-5-sulfonic acid, 2-(p-dimethylaminophenyl)-5-sulfoniobenzoxazoic £cid and mixtures thereof.
10 Particularly preferred are such materials as ethylhexyl p-methoxycinnamate (available as Parsol MCX®), avobenzene (available as Parsol 1789®), octy\sal\cy}ate (available as Dermablock OS®) and iNCI name Terephthalylidene Dicamphor Sulfonic Acid (available as Mexoryl SX®agent).
15 Amounts of the organic sunscreen may range from 0.1 to 15%, preferably from 0.5% to 10%, optimally from 1% to 8% by weight of the composition.
A variety of thickening agents may be included in the compositions. Illustrative but not limiting are acrylamide/sodium acryloyldimethyltaurate copolymer, hydroxyethyl
20 acrylate/sodium acryloyldimethyltaurate copolymer, aluminum starch octenyl succinate, polyacrylates (such as carbomers including Carbopol® 980, Carbopol® 1342, Pemulen TR-2® and the Ultrez® thickeners), polysaccharides (including xanthan gum, guar gum, pectin, carageenan and sclerotium gums), celluloses (including carboxymethyl cellulose, ethyl cellulose, hydroxyethyl cellulose and methyl hydroxymethyl cellulose), minerals
25 (including talc, silica, alumina, mica and clays, the latter being represented by bentonites, hectorites and attapulgites), magnesium aluminum silicate and mixtures thereof. Amounts of the thickeners may range from 0.05 to 10%, preferably from 0.3 to 2% by weight of the compositions.
30 Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms. Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium
35 compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability.


-10-
Particularly preferred preservatives are phenoxyethanol, methyl paraben, propyl paraben, butyl paraben, isobutyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcoho). The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other 5 ingredients in the emulsion. Preservatives are preferably employed in amounts ranging from 0.01% to 2% by weight of the composition.
Compositions of the present invention may also contain vitamins and flavonoids. Illustrative water-soluble vitamins are niacinamide, vitamin B2l vitamin B6; vitamin C and
10 biotin. Among the useful water-insoluble vitamins are vitamin A (retinol), vitamin A palmitate, ascorbyl tetraisopalmitate, vitamin E (tocopherol), vitamin E acetate and DL-panthenol. A particularly suitable vitamin B6 derivative is pyridoxine palmitate. Among the preferred flavonoids are glucosyl hesperidin and rutin. Total amount of vitamins or flavonoids when present in compositions according to the present invention may range
15 from 0.001 to 10%, preferably from 0.01% to 1%, optimally from 0.1 to 0.5% by weight of the composition.
Desquamation agents are further optional components. Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids and salts of these acids. 20 Among the former are salts of glycolic acid, lactic acid and malic acid. Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from 0.1 to 15% by weight of the composition.
A variety of herbal extracts may optionally be included in compositions of this invention, 25 Illustrative are pomegranate, white birch (Betula Alba), green tea, chamomile, licorice, boswellia serrata, olive (Olea Europaea) leaf, arnica montana flower, lavanduia angustifolia, and extract combinations thereof. The extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents. 30
Miscellaneous other adjunct cosmetic ingredients that may be suitable for the present compositions include ceramides (e.g. Ceramide 3 and Ceramide 6), conjugated linoleic acids, colorants (e.g. iron oxides), metal (manganese, copper and/or zinc) gluconates, allantoin, palmitoyl pentapeptide-3, amino acids (e.g. alanine, arginine, glycine, lysine, 35 proline, serine, threonine, glumattc acid and mixtures thereof), trimethylglycine, sodium


-11 -
PCA, magnesium aspartate, and combinations thereof. Amounts may vary from 0.000001 to 2% by weight of the composition.
A small amount of emulsifying surfactant may be present. Surfactants may be anionic, 5 nonionic, cationic, amphoteric and mixtures thereof. Levels may range from 0.1 to 5%, preferably from 0.1 to 2%, optimally from 0.1 to 1% by weight. Advantageously the amount of surfactant present should not be sufficient for lather formation. In these instances, less than 2% by weight, preferably less than 1%, and optimally less than 0.5% by weight surfactant is present.
10
The term "comprising" is meant not to be limiting to any subsequently stated elements but rather to encompass non-specified elements of major or minor functional importance. \n other words the listed steps, elements or options need not be exhaustive. Whenever the words "including" or "having" are used, these terms are meant to be equivalent to
15 "comprising" as defined above.
It should be noted that in specifying any range of concentration or amount, any particular upper concentration can be associated with any particular lower concentration or amount.
20 All documents referred to herein, including all patents, patent applications, and printed publications, are hereby incorporated by reference in their entirety in this disclosure.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by 25 weight unless otherwise illustrated.
EXAMPLES 1-6
A series of formulas to be used as anti-aging creams based on the present invention is provided in table I. 30
18JUN2009

-12-
o
TABLE I g

INGREDIENTS EXAMPLE (weiqht %)
1 2 3 4 5 6
Abil EM-90 (cetyl dimethicone copolyol) 2.0 2.0 1.0 1.0 1.0 1.0
PEG-10dimethicone 1.5 0 1.0 0 0 1.0
Polyglyceryl ricinoleate 2.0 1.0 0 0 0 0.5
Magnesium sulphate 0.5 0 0 0.5 0.5 0.5
Sucrose distearate 0.5 0.5 0 0 0 0
Glycerin 8.0 0 8 10 10 15
Niacinamide 3.0 0 0 2.0 2.0 0.5
Parsol® MCX 7.5 4.0 3.5 0 0 3.5
Z-Cote HP-1 (zinc oxide) 3.0 1.0 0 0 0 0
DC 246 (cyclohexasiloxane, cyclopentasiloxane) 0 20 20 0 0 0
DC 245 (cyclopentasiloxane, cyclotrisiloxane, cyclohexasiloxane, cyclotetrasiloxane) 40 0 0 10 30 15
DC 9045 silicone elastomer blend (dimethicone cross-polymer and cyclopentasiloxane) 15 40 30 30 20 15
Dry Flo Pure 28-1850 (aluminium starch octenylsuccinate, water) 5.0 0 0 5.0 2.0 2.0
Ganzpearl GMP-0820® 0.8 5.0 1.0 0.3 1.0 0.5
Timiron® MP-111 (titanium dioxide coated mica) 1.0 0.8 0.6 0.6 0.6 0.5
Barium Sulfate (single-crystal flat platy) 0.2 0.2 0.4 0.4 0.8 0.8
Pomegranate extract 0.1 0.1 0.3 0.3 0.1 0
Conjugated linoleic acid 0.1 0.1 0.5 1.0 2.0 0.3
Fragrance 0.5 0.5 0.5 0.8 0.8 0.8
Methylparaben 0 0.2 0.2 0 0.2 0
Propylparaben 0 0.1 0.1 0 0.1 0
Phenoxyethanol 0.4 0 0 0 0 0.2
Glydant Plus Liquid® (DMDM hydantoin, ilodopropynyl butylcarbamate) 0.2 0.2 0.2 0.4 0.4 0.4
Water Balance Balance Balance Balance Balance Balance



-13-
EXAMPLES 7-11
A series of moisturizing skin cream/lotion is reported under table II which are useful in the
present invention.
5 TABLE

INGREDIENTS EXAMPLE (weight %)
7 8 9 10 11
PHASE A
Allantoin 0.1 0.1 0.1 0.1 0.1
Disodium EDTA 0.1 0.1 0.1 0.1 0.1
Ethyl paraben 0.2 0.2 0.2 0.2 0.2
Propyl paraben 0.1 0.1 0.1 0.1 0.1
Butylated hydroxy toluene 0.015 0.15 0.01 0.015 0.015
Dexpanthenol 1.0 0.5 1.0 1.0 1.0
Glycerin 7.5 10.0 15.0 7.5 5.0
N-undecylenoyl-L-phenylalanine 2.0 0.5 1.0 4.0 1.0
Hexamidine isethionate 0.0 0.1 0.1 0.0 1.0
Niacinamide 0 3.5 5.0 2.0 2.0
Palmitoyl-pentapeptide(1) 0 0 0 0.0004 0.0003
Phenylbenzimadazole sulfonic acid 0 0 0 0 1.0
Benzyl alcohol 0.25 0.25 0.25 0.25 0.25
Triethanolamine 0.8 0.2 0.40 1.60 1.0
Green tea extract 1.0 1.0 1.0 1.0 1.0
N-Acetyl glucosamine 0.0 5.0 2.0 1.0 5.0
Sodium metabisuifite 0.1 0.1 0.1 0.1 0.1
Water Balance Balance Balance Balance Balance
PHASE B
Cyclopentasiloxane 15.0 15.0 18.0 15.0 15.0
Barium sulphate (single-crystal flat platy) 0.5 0.5 0.75 0.5 0.5
Ganzpearl GMP-0820® 0.5 0.5 0.75 0.3 0.8
PHASE C
C12-C15alkylbenzoate 1.5 0 0 1.5 1.5
Dipalmitoyl hydroxyproline 0 1.0 0 0 1.0
Salicylic acid 1.5 0 0 0 0
PPG-15stearyl ether 4 0 0 0 0
Vitamin E acetate 0.5 0 1.0 0.5 0.5
Retinyl propionate 0.0 0 0 0.2 0.2
Phytosteroi 0.0 0.0 1.0 5.0 3.0
PHASE D
KSG-21 silicone elastomer (2) 4.0 4.0 5.0 4.0 4.0
Dow Coming 9040 silicone elastomer 15.0 15.0 12.0 15.0 15.0
Dimethicone copolyol (3) 0.5 0 0 0.5 0.5
Polymethylsilsesquioxane 2.5 2.5 2.0 2.5 2.5
Fragrance 0.2 0.2 0.2 0.2 0.2000
(1) palmitoyl-pentapeptide = palmitoyl-lysine-threonine-threonine-lysine-serine (available from Sederma)
(2) KSG-21, an emulsifying silicone elastomer (available from Shin Etsu)
(3) Abil EM-97 (available from Goldschmidt Chemical Corporation)


-14-
In a suitable vessel, the phase A components are blended together with a suitable mixer (e.g. Tekmar model RW20DZM) and mixing is continued until all of the components are dissolved. Then the phase B components are blended together in a suitable vessel and are milled using a suitable mill (e.g. Tekmar RW-20) for about five minutes. The phase C
5 components are then added to the phase B mixture with mixing. Then the phase D components are added to the mixture of phases B and C and the resulting combination of phase B, C, and D components is then mixed using a suitable mixer (e.g. Tekmar RW-20) for about one hour. Then phase A is slowly added to the mixture of phases B, C, and D with mixing. The resulting mixture is then continually mixed until the product is uniform.
0 The resulting product is then milled for about five minutes using an appropriate mill (e.g. Tekmar T-25).
EXAMPLES 12-18
A series of formulas were investigated for their optical properties. These are recorded in 5 table III below.
TABLE III

Example (weic ht %)
Component 12 13 14 15 16 17 18
Phase A
DC 246* 9.625 9.625 9.625 9.625 9.625 9.625 9.625
DC 245** 8.105 8.105 8.105 10.605 8.105 10.105 8.105
Z-CoteHP-1 (zinc oxide) 2.000 2.000 2.000 2.000 2.000 2.000 2.000
Phase B
DC 9045 silicone elastomer
blend 45.570 45.570 45.570 45.570 45.570 45.570 45.570
Phase C
Cetyl dimethicone copolyol 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Phase D
Ganzpearl GMP-0820 (acrylates cross-polymer) 2.000 2.000 2.000 0-000 2.000 0.000 2.000
TimironMP-111*** 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Barium sulfate HL (single crystal platy) 0.500 0,000 0.000 0.000 0.000 0.500 0.000
Barium sulfate LLD-5 (spherical) 0.000 0.500 0.000 0.000 0.000 0.000 0.000
Barium sulfate (KOBO) 0.000 0.000 0.500 0.000 0.000 0.000 0.000
Barium sulfate HG 0.000 0.000 0.000 0.000 0.000 0.000 0.500
Phase E
Deionized water 10.000 10.000 10.000 10.000 10.000 10.000 10.000
Glycerin 15.000 15.000 15.000 15.000 15.000 15.000 15.000
Glydant Plus Liquid**** 0.200 0.200 0.200 0.200 0.200 0.200 0.200

-15-

Phase F
Aluminum starch octenylsuccinate 5.000 5.000 5.000 5.000 5.000 5.000 5.000
* Cyclohexasiloxane and cyclopentasiloxane.
** Cyclopentasiloxane, cyclotriloxane, cyclohexasiloxane and cyclotetrasiloxane 5 *** Titanium dioxide coated mica.
**** DMDM hydantoin, iodopropynyl butyl carbonate, butylene glycol and water
The formulas in Table III were blended in the following manner. Phase A was prepared 10 by adding zinc oxide into DC 245 and DC 246 until dispersed. Phase A was then added to phase B in a main reactor under propeller mixing. Phase C was then added to phase A/B while maintaining mixing for a ten minute period until uniform. Phase D powders were then added to phase A/B/C individually, using slow addition to avoid clumping. Premixed phase E was added and mixed until uniform. Phase F was then added to the 15 other phases under slow addition to avoid clumping. The batch was then homogenized for ten minutes.
Optical Measurements
Opacity is the measure of intensity attenuation of a transmitted light beam shone
20 perpendicular to a medium or film. The higher the direct beam attenuation, the greater will be the opacity. The source of the light beam attenuation is two fold. Some of the original light is reflected back from the film/medium. This gives the film/medium a true white/opaque appearance with great hiding power. Using pigment-grade TiO2 in a formulation will give the effect. Some of the light is deflected from the straight beam path
25 but still transmitted through the film/medium. In effect, the film/medium goes from being transparent to translucent, creating a "blurred" image. Another term for this is soft focus.
Procedure: Apply (or draw down) a 3 mil (76.2 m) film of a formulation using a draw down bar on to a plastic overhead transparency sheet. Let the film dry for two hours at
30 room temperature. Take the coated overhead transparency and place it in an Instrument Systems goniospectrophotometer. Set the light source and detector arrayed in a straight line perpendicular to the coated transparency. The light source (set at 209 million Watt-nm/cm2, which serves as a reference for all Transmission Intensity values reported herein) is turned on and the measurement of the transmitted light intensity is made.
35 Further measurements are made by moving the detector 10, 30, 40 and 50 degrees away
JUN2009

-16-
from the direct transmission normal. These values indicate the extent of soft focus light scattering. The reflectance or "radiance" of a product is determined in the same way as opacity/soft focus light scattering, except for the positions of the light source and detector. The detector is 20 or 30 degrees on one side of the normal/perpendicular, while the light 5 source is 20 degrees on the other side. To determine the extent of the intensity attenuation, compare the intensity value to that of an uncoated overhead transparency. The difference between these two values is the extent of the attenuation or opacity.
Results: The effect of certain components on the optical properties of the compositions 10 was evaluated by testing formulations with those components removed. The results are reported in table IV. The acceptability range values are for facial color management which provides soft focus but minimizes shininess and regulates opacification. Numbers in bold are values found outside the Acceptability ranges.
15 TABLE IV

Example (W-nm/cm^)
Trans¬mission angle in degrees 12 13 14 15 16 17 18 Acceptability Transmission
Intensity (Watt-nm/cm2)
0 6.11 M 3.36 M 5.16 M 8.45 M 3.82 M 5.52 M 6.52 M 4 to 7 million
10 1.02 M 835.2K 987.5 K 967.8 K 1.12M 1.15M LOOM 1 to 2 million
30 129.72M 139.91 K 135.9 K 124.9 K 132.9 K 124.72K 123.52K 120 to 140 thousand
40 80.51 K 95.86K 85.91 K 78.04 K 80.50 K 75.25 K 74.15 K 60 to 85 thousand
50 55.75 K 64.75K 58.91 K 54.12 K 56.40 K 52.55 K 51.65 K 40 to 60 thousand
Reflection angle in degrees
20 147.66 K 92.44K 128 K 140.51 K 111.26K 161.2 K 167.2 K 140 to 160 Thousand
30 109.40 K 84.68K 102.0 K 107.39 K 93.03 K 115.2 K 116.2 K 90 to 110 Thousand
Examples 12, 13, 14 and 18 represent a base formula with a combination of different barium sulfates each with a powdered acrylic polymer (Ganzpearl GMP-0820). The 20 respective barium sulfates are HL (single crystal platy) with average particle size 11-12 micron (example 12), LLD-5 (spherical) with average particle size 1 micron or less (example 13), Kobo (single crystal platy) with average particle size 5 micron (example 14), and HG (single crystal platy) with average particle size 20 micron (example 18). In almost all transmission angle and reflection angle measurements the value result for


-17-
example 13 was outside acceptability parameters. It is evident that a spherical barium sulfate is significantly inferior to the single crystal platy variety represented by the inventive example 12. Although useful for the present invention, platy barium sulfate of 5 micron and of 20 micron (examples 14 and 18) performed slightly less well than the 11-12 5 micron size barium sulfate. Examples 15, 16 and 17 represent control experiments where either the single crystal platy barium sulfate or the Ganzpearl or both components were absent from the base formula. In all these experiments, there was a significant deviation from acceptability range.

-18-
CLAIMS
1. A cosmetic composition comprising:
(i) from about 0.01 to about 10% of single-crystal platy barium sulfate by weight
5 of the composition;
(ii) from about 0.1 to about 10% of a water-insoluble powdered acrylic polymer in
porous particle form; and (iii) a cosmetically acceptable carrier,
wherein the number average particle size of the single-crystal platy barium sulfate is
10 ■ from 8 to 15 microns.
2. A composition according to claim 1, wherein the acrylic polymer is a methyl
methacrylate crosspolymer.
15 3. A composition according to claim 1 which is a water-in-oil emuision.
4. A composition according to claim 3, wherein the emulsion is emulsified by a dimethicone copolyol surfactant.
20 5. A composition according to claim 1,.wherein the barium sulfate is not coated with any organic coating.
6., A composition according to claim 1, wherein the barium sulfate is present in an
amount from 0.1 to 1% by weight of the composition. 25
7. A composition according to claim 1, wherein the powdered acrylic polymer has a
porosity as measured by Oil Absorbance (Castor Oil) ranging from 90 to 500 ml/100
grams.
30 8. A composition according to claim 1, wherein the powdered acrylic poiymer in porous particle form has a particle density ranging from 0.08 to 0.55 g/cm3.
Dated this 18th dayof June 2009

35

HINDUSTAN UNILEVER LIMITED
(S. Verikatramani)
AMENDED SHEET Head of Patent Group India

Documents

Orders

Section Controller Decision Date
15 A.T.Patre 2014-06-16
15 A.T.Patre 2014-06-16

Application Documents

# Name Date
1 1161-MUMNP-2009-ANNEXURE TO FORM 3(20-3-2013).pdf 2018-08-10
1 1161-MUMNP-2009-OTHER DOCUMENT(10-10-2012).pdf 2012-10-10
2 1161-mumnp-2009-assingment.pdf 2018-08-10
2 1161-MUMNP-2009-FORM 3(10-10-2012).pdf 2012-10-10
3 1161-MUMNP-2009-FORM 3-(10-12-2013).pdf 2013-12-10
3 1161-MUMNP-2009-CLAIMS(GRANTED)-(16-6-2014).pdf 2018-08-10
4 1161-MUMNP-2009_EXAMREPORT.pdf 2018-08-10
4 1161-mumnp-2009-claims.doc 2018-08-10
5 1161-mumnp-2009-wo international publication report a3.pdf 2018-08-10
5 1161-mumnp-2009-claims.pdf 2018-08-10
6 1161-mumnp-2009-wo international publication report a2.pdf 2018-08-10
6 1161-MUMNP-2009-CORRESPONDENCE(1-8-2013).pdf 2018-08-10
7 1161-mumnp-2009-separate sheet-409.pdf 2018-08-10
7 1161-MUMNP-2009-CORRESPONDENCE(10-8-2009).pdf 2018-08-10
8 1161-MUMNP-2009-REPLY TO HEARING(24-3-2014).pdf 2018-08-10
8 1161-MUMNP-2009-CORRESPONDENCE(26-8-2013).pdf 2018-08-10
9 1161-MUMNP-2009-CORRESPONDENCE(7-6-2013).pdf 2018-08-10
9 1161-MUMNP-2009-REPLY TO EXAMINATION REPORT(20-3-2013).pdf 2018-08-10
10 1161-MUMNP-2009-CORRESPONDENCE(9-9-2010).pdf 2018-08-10
10 1161-MUMNP-2009-OTHER DOCUMENT(20-3-2013).pdf 2018-08-10
11 1161-MUMNP-2009-CORRESPONDENCE(IPO)-(17-6-2014).pdf 2018-08-10
11 1161-MUMNP-2009-OTHER DOCUMENT(10-8-2009).pdf 2018-08-10
12 1161-MUMNP-2009-CORRESPONDENCE(IPO)-(24-7-2009).pdf 2018-08-10
12 1161-MUMNP-2009-GENERAL POWER OF ATTORNEY(20-3-2013).pdf 2018-08-10
13 1161-mumnp-2009-correspondence.pdf 2018-08-10
13 1161-mumnp-2009-form-pct-isa-210.pdf 2018-08-10
14 1161-mumnp-2009-declaration.pdf 2018-08-10
14 1161-mumnp-2009-form-pct-ipea-416.pdf 2018-08-10
15 1161-mumnp-2009-form-pct-ipea-409.pdf 2018-08-10
16 1161-mumnp-2009-description(complete).pdf 2018-08-10
16 1161-MUMNP-2009-FORM 5(18-6-2009).pdf 2018-08-10
17 1161-mumnp-2009-form 3.pdf 2018-08-10
17 1161-MUMNP-2009-DESCRIPTION(GRANTED)-(16-6-2014).pdf 2018-08-10
18 1161-MUMNP-2009-FORM 3(8-8-2012).pdf 2018-08-10
18 1161-mumnp-2009-form 1.pdf 2018-08-10
19 1161-MUMNP-2009-FORM 13(9-2-2012).pdf 2018-08-10
19 1161-MUMNP-2009-FORM 3(4-8-2010).pdf 2018-08-10
20 1161-MUMNP-2009-FORM 18(9-9-2010).pdf 2018-08-10
20 1161-MUMNP-2009-FORM 3(24-2-2010).pdf 2018-08-10
21 1161-MUMNP-2009-FORM 2(GRANTED)-(16-6-2014).pdf 2018-08-10
21 1161-MUMNP-2009-FORM 3(23-1-2013).pdf 2018-08-10
22 1161-MUMNP-2009-FORM 2(TITLE PAGE)-(GRANTED)-(16-6-2014).pdf 2018-08-10
22 1161-MUMNP-2009-FORM 3(22-6-2013).pdf 2018-08-10
23 1161-mumnp-2009-form 2(title page).pdf 2018-08-10
23 1161-MUMNP-2009-FORM 3(15-2-2012).pdf 2018-08-10
24 1161-MUMNP-2009-FORM 3(15-2-2011).pdf 2018-08-10
25 1161-MUMNP-2009-FORM 3(12-8-2011).pdf 2018-08-10
25 1161-mumnp-2009-form 2.pdf 2018-08-10
26 1161-MUMNP-2009-FORM 3 (21-5-2014).pdf 2018-08-10
26 1161-MUMNP-2009-FORM 3(10-8-2009).pdf 2018-08-10
27 1161-MUMNP-2009-FORM 3 (21-5-2014).pdf 2018-08-10
27 1161-MUMNP-2009-FORM 3(10-8-2009).pdf 2018-08-10
28 1161-mumnp-2009-form 2.pdf 2018-08-10
28 1161-MUMNP-2009-FORM 3(12-8-2011).pdf 2018-08-10
29 1161-MUMNP-2009-FORM 3(15-2-2011).pdf 2018-08-10
30 1161-mumnp-2009-form 2(title page).pdf 2018-08-10
30 1161-MUMNP-2009-FORM 3(15-2-2012).pdf 2018-08-10
31 1161-MUMNP-2009-FORM 2(TITLE PAGE)-(GRANTED)-(16-6-2014).pdf 2018-08-10
31 1161-MUMNP-2009-FORM 3(22-6-2013).pdf 2018-08-10
32 1161-MUMNP-2009-FORM 2(GRANTED)-(16-6-2014).pdf 2018-08-10
32 1161-MUMNP-2009-FORM 3(23-1-2013).pdf 2018-08-10
33 1161-MUMNP-2009-FORM 18(9-9-2010).pdf 2018-08-10
33 1161-MUMNP-2009-FORM 3(24-2-2010).pdf 2018-08-10
34 1161-MUMNP-2009-FORM 13(9-2-2012).pdf 2018-08-10
34 1161-MUMNP-2009-FORM 3(4-8-2010).pdf 2018-08-10
35 1161-mumnp-2009-form 1.pdf 2018-08-10
35 1161-MUMNP-2009-FORM 3(8-8-2012).pdf 2018-08-10
36 1161-mumnp-2009-form 3.pdf 2018-08-10
36 1161-MUMNP-2009-DESCRIPTION(GRANTED)-(16-6-2014).pdf 2018-08-10
37 1161-MUMNP-2009-FORM 5(18-6-2009).pdf 2018-08-10
37 1161-mumnp-2009-description(complete).pdf 2018-08-10
38 1161-mumnp-2009-form-pct-ipea-409.pdf 2018-08-10
39 1161-mumnp-2009-declaration.pdf 2018-08-10
39 1161-mumnp-2009-form-pct-ipea-416.pdf 2018-08-10
40 1161-mumnp-2009-correspondence.pdf 2018-08-10
40 1161-mumnp-2009-form-pct-isa-210.pdf 2018-08-10
41 1161-MUMNP-2009-CORRESPONDENCE(IPO)-(24-7-2009).pdf 2018-08-10
41 1161-MUMNP-2009-GENERAL POWER OF ATTORNEY(20-3-2013).pdf 2018-08-10
42 1161-MUMNP-2009-OTHER DOCUMENT(10-8-2009).pdf 2018-08-10
42 1161-MUMNP-2009-CORRESPONDENCE(IPO)-(17-6-2014).pdf 2018-08-10
43 1161-MUMNP-2009-CORRESPONDENCE(9-9-2010).pdf 2018-08-10
43 1161-MUMNP-2009-OTHER DOCUMENT(20-3-2013).pdf 2018-08-10
44 1161-MUMNP-2009-CORRESPONDENCE(7-6-2013).pdf 2018-08-10
44 1161-MUMNP-2009-REPLY TO EXAMINATION REPORT(20-3-2013).pdf 2018-08-10
45 1161-MUMNP-2009-CORRESPONDENCE(26-8-2013).pdf 2018-08-10
45 1161-MUMNP-2009-REPLY TO HEARING(24-3-2014).pdf 2018-08-10
46 1161-mumnp-2009-separate sheet-409.pdf 2018-08-10
46 1161-MUMNP-2009-CORRESPONDENCE(10-8-2009).pdf 2018-08-10
47 1161-mumnp-2009-wo international publication report a2.pdf 2018-08-10
47 1161-MUMNP-2009-CORRESPONDENCE(1-8-2013).pdf 2018-08-10
48 1161-mumnp-2009-wo international publication report a3.pdf 2018-08-10
48 1161-mumnp-2009-claims.pdf 2018-08-10
49 1161-MUMNP-2009_EXAMREPORT.pdf 2018-08-10
50 1161-MUMNP-2009-FORM 3-(10-12-2013).pdf 2013-12-10
50 1161-MUMNP-2009-CLAIMS(GRANTED)-(16-6-2014).pdf 2018-08-10
51 1161-MUMNP-2009-FORM 3(10-10-2012).pdf 2012-10-10
51 1161-mumnp-2009-assingment.pdf 2018-08-10
52 1161-MUMNP-2009-ANNEXURE TO FORM 3(20-3-2013).pdf 2018-08-10
52 1161-MUMNP-2009-OTHER DOCUMENT(10-10-2012).pdf 2012-10-10

ERegister / Renewals

3rd: 18 Aug 2014

From 04/12/2009 - To 04/12/2010

4th: 18 Aug 2014

From 04/12/2010 - To 04/12/2011

5th: 18 Aug 2014

From 04/12/2011 - To 04/12/2012

6th: 18 Aug 2014

From 04/12/2012 - To 04/12/2013

7th: 18 Aug 2014

From 04/12/2013 - To 04/12/2014

8th: 18 Aug 2014

From 04/12/2014 - To 04/12/2015

9th: 28 Nov 2015

From 04/12/2015 - To 04/12/2016

10th: 17 Nov 2016

From 04/12/2016 - To 04/12/2017